235 related articles for article (PubMed ID: 19222901)
21. Preclinical pharmacokinetic properties of the P-glycoprotein inhibitor GF120918A (HCl salt of GF120918, 9,10-dihydro-5-methoxy-9-oxo-N-[4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]phenyl]-4-acridine-carboxamide) in the mouse, rat, dog, and monkey.
Ward KW; Azzarano LM
J Pharmacol Exp Ther; 2004 Aug; 310(2):703-9. PubMed ID: 15056727
[TBL] [Abstract][Full Text] [Related]
22. Expression levels of human P-glycoprotein in in vitro cell lines: correlation between mRNA and protein levels for P-glycoprotein expressed in cells.
Shirasaka Y; Konishi R; Funami N; Kadowaki Y; Nagai Y; Sakaeda T; Yamashita S
Biopharm Drug Dispos; 2009 Apr; 30(3):149-52. PubMed ID: 19243013
[TBL] [Abstract][Full Text] [Related]
23. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery.
Sakagami M
Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1030-60. PubMed ID: 17010473
[TBL] [Abstract][Full Text] [Related]
24. Effects of capsaicin on P-gp function and expression in Caco-2 cells.
Han Y; Tan TM; Lim LY
Biochem Pharmacol; 2006 Jun; 71(12):1727-34. PubMed ID: 16674925
[TBL] [Abstract][Full Text] [Related]
25. Cross-functioning between the extraneuronal monoamine transporter and multidrug resistance protein 1 in the uptake of adrenaline and export of 5-(glutathion-S-yl)adrenaline in rat cardiomyocytes.
Costa VM; Ferreira LM; Branco PS; Carvalho F; Bastos ML; Carvalho RA; Carvalho M; Remio F
Chem Res Toxicol; 2009 Jan; 22(1):129-135. PubMed ID: 19053318
[TBL] [Abstract][Full Text] [Related]
26. Selamectin is a potent substrate and inhibitor of human and canine P-glycoprotein.
Griffin J; Fletcher N; Clemence R; Blanchflower S; Brayden DJ
J Vet Pharmacol Ther; 2005 Jun; 28(3):257-65. PubMed ID: 15953199
[TBL] [Abstract][Full Text] [Related]
27. Kinetic identification of membrane transporters that assist P-glycoprotein-mediated transport of digoxin and loperamide through a confluent monolayer of MDCKII-hMDR1 cells.
Acharya P; O'Connor MP; Polli JW; Ayrton A; Ellens H; Bentz J
Drug Metab Dispos; 2008 Feb; 36(2):452-60. PubMed ID: 17967933
[TBL] [Abstract][Full Text] [Related]
28. Effect of interferon-gamma on the pharmacokinetics of digoxin, a P-glycoprotein substrate, intravenously injected into the mouse.
Kawaguchi H; Matsui Y; Watanabe Y; Takakura Y
J Pharmacol Exp Ther; 2004 Jan; 308(1):91-6. PubMed ID: 14569074
[TBL] [Abstract][Full Text] [Related]
29. Effect of hr-IL2 treatment on intestinal P-glycoprotein expression and activity in Caco-2 cells.
Belliard AM; Tardivel S; Farinotti R; Lacour B; Leroy C
J Pharm Pharmacol; 2002 Aug; 54(8):1103-9. PubMed ID: 12195825
[TBL] [Abstract][Full Text] [Related]
30. Human respiratory epithelial cell culture for drug delivery applications.
Forbes B; Ehrhardt C
Eur J Pharm Biopharm; 2005 Jul; 60(2):193-205. PubMed ID: 15939233
[TBL] [Abstract][Full Text] [Related]
31. Utility of 96 well Caco-2 cell system for increased throughput of P-gp screening in drug discovery.
Balimane PV; Patel K; Marino A; Chong S
Eur J Pharm Biopharm; 2004 Jul; 58(1):99-105. PubMed ID: 15207543
[TBL] [Abstract][Full Text] [Related]
32. P-glycoprotein-mediated efflux of phenobarbital at the blood-brain barrier evidence from transport experiments in vitro.
Yang ZH; Liu XD
Epilepsy Res; 2008 Jan; 78(1):40-9. PubMed ID: 18063342
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of P-glycoprotein-mediated transport by terpenoids contained in herbal medicines and natural products.
Yoshida N; Koizumi M; Adachi I; Kawakami J
Food Chem Toxicol; 2006 Dec; 44(12):2033-9. PubMed ID: 16904803
[TBL] [Abstract][Full Text] [Related]
34. Digoxin-cyclosporin A interaction: modulation of the multidrug transporter P-glycoprotein in the kidney.
Okamura N; Hirai M; Tanigawara Y; Tanaka K; Yasuhara M; Ueda K; Komano T; Hori R
J Pharmacol Exp Ther; 1993 Sep; 266(3):1614-9. PubMed ID: 8103797
[TBL] [Abstract][Full Text] [Related]
35. Modulating effect of polyethylene glycol on the intestinal transport and absorption of prednisolone, methylprednisolone and quinidine in rats by in-vitro and in-situ absorption studies.
Shen Q; Li W; Lin Y; Katsumi H; Okada N; Sakane T; Fujita T; Yamamoto A
J Pharm Pharmacol; 2008 Dec; 60(12):1633-41. PubMed ID: 19000368
[TBL] [Abstract][Full Text] [Related]
36. Selectivity in the impact of P-glycoprotein upon pulmonary absorption of airway-dosed substrates: a study in ex vivo lung models using chemical inhibition and genetic knockout.
Al-Jayyoussi G; Price DF; Francombe D; Taylor G; Smith MW; Morris C; Edwards CD; Eddershaw P; Gumbleton M
J Pharm Sci; 2013 Sep; 102(9):3382-94. PubMed ID: 23670704
[TBL] [Abstract][Full Text] [Related]
37. Polysorbate 20 increases oral absorption of digoxin in wild-type Sprague Dawley rats, but not in mdr1a(-/-) Sprague Dawley rats.
Nielsen CU; Abdulhussein AA; Colak D; Holm R
Int J Pharm; 2016 Nov; 513(1-2):78-87. PubMed ID: 27601334
[TBL] [Abstract][Full Text] [Related]
38. P-glycoprotein-mediated transport of oxytetracycline in the Caco-2 cell model.
Schrickx J; Fink-Gremmels J
J Vet Pharmacol Ther; 2007 Feb; 30(1):25-31. PubMed ID: 17217397
[TBL] [Abstract][Full Text] [Related]
39. Drug-drug interactions mediated through P-glycoprotein: clinical relevance and in vitro-in vivo correlation using digoxin as a probe drug.
Fenner KS; Troutman MD; Kempshall S; Cook JA; Ware JA; Smith DA; Lee CA
Clin Pharmacol Ther; 2009 Feb; 85(2):173-81. PubMed ID: 18987624
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the modulation of P-glycoprotein (P-gp) on the intraocular disposition of its substrate in rabbits.
Senthilkumari S; Velpandian T; Biswas NR; Saxena R; Ghose S
Curr Eye Res; 2008 Apr; 33(4):333-43. PubMed ID: 18398708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]